Form D · Biotechnology
X-Co Holdings, LP
Wilmington, NC · CIK 0001661660
Offering snapshot reported Jan 12, 2016 · SEC filing
- Reported sold
- $71M Offering amount: $71M
- Investors reported
- 46 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 29, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2016 | Initial | $71,049,789 | No comparison | 46 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254974
Source: Form D, filed Jan 12, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joe Bress | Director |
| Stephen Ensley | Director |
| B. Judd Hartman | Executive |
| Ram M. Jagannath | Director |
| N/A X Co Holdings Gp, Llc | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Pharmaceutical Product Development 929 North Front Street
Wilmington, NC, 28401
Wilmington, NC, 28401